USMLE Step 1 practice question: Basal cell carcinoma: hedgehog pathway and Smoothened inhibitors

USMLE Step 1DermatologyPathology

A 74-year-old man comes to the physician because of a slowly enlarging, bleeding lesion on his left cheek near the inner corner of the eye for 3 years. He worked outdoors as a roofer for 40 years. Examination shows a 4-cm ulcerated plaque with pearly, rolled borders and arborizing telangiectasias that extends toward the orbit. Biopsy shows nests of basaloid cells with peripheral palisading of nuclei and clefts separating the tumor nests from the surrounding stroma. MRI shows invasion of the medial orbital wall. There is no evidence of distant spread. After multidisciplinary review, surgery and radiation therapy are judged inappropriate, and an oral targeted agent is started.

This agent most likely inhibits which of the following proteins?

  1. BRAF, a serine-threonine kinase in the MAPK signaling cascade
  2. Frizzled, a receptor that stabilizes beta-catenin in Wnt signaling
  3. mTOR, a kinase that promotes protein synthesis downstream of PI3K-AKT
  4. Smoothened, a transmembrane protein normally repressed by Patched
  5. Janus kinase 2, which phosphorylates STAT proteins after cytokine binding
Show answer and explanation

Correct answer: D. Smoothened, a transmembrane protein normally repressed by Patched

A pearly, rolled-border plaque with arborizing telangiectasias and central ulceration on sun-exposed facial skin, with nests of basaloid cells showing peripheral palisading and retraction clefts, is basal cell carcinoma (BCC). BCC is the most common skin cancer; it rarely metastasizes but can be locally destructive, as with this orbital invasion.

Nearly all BCCs have constitutive activation of the Hedgehog signaling pathway. Normally, the Patched 1 receptor (PTCH1) represses Smoothened (SMO), a 7-transmembrane signal transducer. When a Hedgehog ligand binds PTCH1, this repression is relieved, and SMO activates GLI transcription factors that drive proliferation genes. In most sporadic BCCs, PTCH1 is inactivated by mutation (often with a UV-signature pattern); fewer tumors carry activating SMO mutations. Germline PTCH1 mutations cause nevoid basal cell carcinoma (Gorlin) syndrome, with many BCCs from a young age, odontogenic keratocysts of the jaw, palmar pits and medulloblastoma.

Because the pathway is activated at the level of SMO or above it, the oral SMO inhibitors vismodegib and sonidegib are used for locally advanced BCC not amenable to surgery or radiation and for metastatic BCC. Adverse effects reflect Hedgehog signaling in normal tissues: muscle spasms, dysgeusia, alopecia, weight loss and fatigue; the drugs are teratogenic. The PD-1 inhibitor cemiplimab is an option after Hedgehog inhibitor failure or intolerance.

Why the other options are wrong

  • A. BRAF, a serine-threonine kinase in the MAPK signaling cascade — BRAF V600E inhibitors such as vemurafenib and dabrafenib treat melanoma; the MAPK pathway is not the main driver of basal cell carcinoma.
  • B. Frizzled, a receptor that stabilizes beta-catenin in Wnt signaling — Frizzled receptors bind Wnt ligands; Wnt-beta-catenin activation characterizes colorectal cancer with APC loss, not basal cell carcinoma.
  • C. mTOR, a kinase that promotes protein synthesis downstream of PI3K-AKT — mTOR inhibitors such as everolimus are used in renal cell carcinoma and tuberous sclerosis complex, not as targeted therapy for basal cell carcinoma.
  • E. Janus kinase 2, which phosphorylates STAT proteins after cytokine binding — JAK2 inhibitors such as ruxolitinib treat myeloproliferative neoplasms with JAK2 V617F, not basal cell carcinoma.

Key point

Basal cell carcinoma is driven by Hedgehog pathway activation, usually from loss of PTCH1, and locally advanced disease is treated with Smoothened inhibitors such as vismodegib.

Memory hook

Patched is the brake, Smoothened the accelerator: BCC loses the brake, so vismodegib takes the foot off the gas.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Pemphigus vulgaris: autoantibodies against desmoglein 3USMLE Step 1 · DermatologyNecrotizing soft tissue infection: emergency surgical debridement with broad-spectrum antibioticsUSMLE Step 2 CK · DermatologyChronic aortic regurgitationUSMLE Step 1 · CardiovascularPharmacokinetics: volume of distribution and oral loading doseUSMLE Step 1 · PharmacologyAutosomal recessive recurrence risk (cystic fibrosis, unaffected sibling = 2/3 carrier)USMLE Step 1 · GeneticsAcyclovir-resistant HSV: thymidine kinase deficiencyUSMLE Step 1 · Microbiology

All free questions →